NCT07465341Recruiting
Michigan Weight Navigation Program (MiWeigh) Study
The Michigan Weight Navigation Program (MiWeigh) Study
Source: ClinicalTrials.gov · Last updated 12 Jun 2026
Brief summary (registry, in English)
The main purpose of this study is to determine whether people who participate in MiWeigh lose more weight than people who receive information about weight loss strategies and programs. The researchers also want to learn what parts of the program do and do not work and why. If the program is effective, the researchers want to learn how other health care systems could offer this program. The overarching aim of the MiWeigh Study is to better help patients prevent, manage, or reverse obesity-related chronic conditions.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- First submitted
- 6 Mar 2026
- Start date
- 9 Apr 2026
- Primary completion date
- 30 Sept 2028
- Lead sponsor
- University of Michigan
- Diseases
- Obesity
- NCT number
- NCT07465341
What you commit to
- Study type: Interventional
- Planned participants: 500
- From 9 Apr 2026 to the primary completion date, 30 Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- ≥ 5% weight loss within the prior 12 months
- Taking an anti-obesity medication
- Bariatric/ gastric bypass surgery, gastric sleeve surgery, or gastric balloon procedure in last year
- Currently enrolled in an interventional research study that is examining how a diet, program, or drug might: promote physical exercise, healthy eating habits, or weight loss; lower blood pressure; or lower blood sugar
Other illness
- Ever diagnosed with Type 1 Diabetes Mellitus (per protocol)
- Dementia
- Serious uncontrolled mental health conditions as indicated (per protocol)
- Chronic kidney disease, Stage 4 or higher
- History of anorexia or bulimia
- Intensive cancer treatment such as bone marrow transplant, chemotherapy, radiation, or cancer related surgery (not including hormonal chemotherapy like Tamoxifen) in last six months or next 12 months
Other
- Has had a Weight Navigation Program visit in past
- Pregnant, planning a pregnancy, or breastfeeding in the next year
- Ongoing participation in another weight-loss program
- Alcohol dependence and opioid dependence (per protocol)
- Not planning to live in local area over the next year
- Other serious health issues or personal concerns that could prevent participant from completing study
Who the study is looking for
- Body Mass index (BMI) 30 kilogram per square meter or higher
- Diagnosed with one or more of the following weight-related conditions:
- Type 2 Diabetes
- Prediabetes Mellitus
- Hyperlipidemia (HLP)
- Hypertension (HTN)
- Polycystic Ovary Syndrome (PCOS)
- Obstructive Sleep Apnea (OSA) and/or
- Metabolic dysfunction-associated steatotic liver disease (MASLD)
- Speaks English
- Interest in losing weight
- Willingness to complete assessments per study protocol
- Willing and able to use the Electronic health records patient portal to respond to messages
- Willing to report weight weekly by text if randomized to intervention arm
- Able to see provider virtually at certain days/times up to four times in a year
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Coordinator of this site? Confirm its status | Ann Arbor | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.